L-lysine Increases the Anticancer Effect of Doxorubicin in Breast Cancer by Inducing ROS-Dependent Autophagy

Keyphrases

• Lysine 100%
• Breast Cancer 100%
• Reactive Oxygen Species 100%
• Anticancer Effect 100%
• Doxorubicin 100%
• Autophagy 100%
• Species-dependent 100%
• Autophagy Pathway 62%
• Cytotoxicity 37%
• Flow Cytometric Analysis 25%
• Arginase Activity 25%
• MDA-MB-468 25%
• Triple-negative Breast Cancer Cells 25%
• Gene Expression 12%
• Quantitative PCR 12%
• Western Blot Analysis 12%
• Breast Cancer Patients 12%
• Combination Therapy 12%
• Protein Expression 12%
• Activity Assay 12%
• Cell Death 12%
• In Cancer 12%
• Cancer Treatment 12%
• Triple-negative Breast Cancer 12%
• Nitric Oxide Level 12%
• Cell Viability 12%
• Cancer Therapy 12%
• Nitric Oxide Production 12%
• Drug Resistance 12%
• MTT Assay 12%
• Griess Reaction 12%
• Adjunct Therapy 12%
• Cytotoxic Effect 12%
• Breast Cancer Cell Lines 12%
• Apoptotic Changes 12%
• Cytotoxic Drugs 12%
• Autophagy-related Genes 12%
• Assay Kit 12%
• Autophagic Flux 12%
• MDA-MB-231 12%
• Chemotherapy Drugs 12%
• Cell Cycle Profile 12%
• Autophagy-related Proteins 12%
• G2-M Arrest 12%
• MDA-MB-231 Cancer Cells 12%
• Cytoprotective Autophagy 12%
• Resistance Induction 12%
• Apoptotic Assay 12%
• Reaction Activity 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Breast Cancer 100%
• Lysine 100%
• Reactive Oxygen Metabolite 100%
• Doxorubicin 100%
• Malignant Neoplasm 37%
• Cytotoxicity 37%
• Triple Negative Breast Cancer 37%
• Nitric Oxide 25%
• Arginase 25%
• Cytoprotective Agent 12%
• Combination Therapy 12%
• Western Blot 12%
• Chemotherapy 12%
• Drug Resistance 12%
• Cell Viability 12%